Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Poor China data caps turbulent week for FTSE 100 as investors rush for exits

Published 14/12/2018, 17:16
Updated 14/12/2018, 17:16
© Reuters. Pedestrians leave and enter the London Stock Exchange in London

By Helen Reid and Muvija M

LONDON (Reuters) - Weak economic data from China sent Britain's top stock index down on Friday as miners, consumer stocks and banks suffered from investors' mounting anxiety about the world's second-biggest economy.

The FTSE 100 (FTSE) ended the day down 0.7 percent, while the FTSE 250 (FTMC) fell 0.9 percent. The leading stocks index still managed a gain for the week, which saw Prime Minister May win a vote of no confidence on Wednesday.

May's attempt to renegotiate her deal with the European Union did little to dispel investor concerns over Brexit, though, sending sterling down 0.8 percent on Friday.

Banks and miners were the biggest drag as the weak data added to persisting fears over slowing growth in China, amid its trade dispute with the United States.

China's November retail sales grew at the weakest pace since 2003 and industrial output rose at the slowest rate in nearly three years as domestic demand softened further.

Mining stocks dropped as London copper was on course for a third straight weekly loss.

Glencore (L:GLEN) dropped 1.7 percent while Rio Tinto (L:RIO), BHP (L:BHPB), and Anglo American (L:AAL) fell between 0.6 and 1.5 percent.

Overall global earnings estimates for next year have begun to fall as analysts adjust to a slower pace of global growth with weak economic data piling up from Europe and China.

"Volatility and the number of sharp moves across assets appear to be rising and investors are facing a challenging macro backdrop," wrote Goldman Sachs (NYSE:GS) strategists.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Investors pulled a record amount from global equity funds this week, data from EPFR showed on Friday. UK equity funds were also set for a record year of outflows with $9.8 billion flooding out so far in 2018.

Helping the FTSE 100 come back from its earlier sharp losses were energy stocks and Astrazeneca (L:AZN) which gained after SunTrust gave it a "buy" rating.

But the FTSE 100, along with euro zone stocks (STOXXE) and the pan-European index (STOXX), was on track for its worst quarter since 2011 when Europe was in the throes of a sovereign debt crisis.

Housebuilders Taylor Wimpey (L:TW), Persimmon (L:PSN), and Barratt Development (L:BDEV) fell 1.8 to 2.7 percent as doubts persisted over Prime Minister May's ability to secure tweaks to her Brexit deal from EU leaders.

A pessimistic note from Canaccord Genuity analysts didn't help the mood.

"Value potential is extremely attractive but macro risks are exceptionally high," the analysts wrote.

In single-stock moves, GVC (L:GVC) shares jumped 8.8 percent ahead of next week's parliamentary vote on maximum stakes on fixed-odds betting terminals.

Citi analysts said the vote would be a "significant positive catalyst" for the stock, eliminating the possibility the company would have to pay out around 676 million pounds to shareholders.

GVC agreed to pay, as part of its acquisition of Ladbrokes (LON:LCL) Coral in March this year, a contingent value right (CVR) linked to the legislation, and worth 35p per Ladbrokes Coral share if the legislation is not enacted by 28 March 2019.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In results, construction firm Balfour Beatty (L:BALF) climbed 4.1 percent after saying full-year profits would beat expectations thanks to the proceeds from the sale of an infrastructure investment this month.

Construction materials firm Low & Bonar (L:LWB), however, saw its shares fall 16.8 percent, the biggest drop on the FTSE small-caps index (FTSC), after it said tough market and trading conditions persisted during its fourth quarter.

Drugmaker Indivior (L:INDV) topped the FTSE 250, up 8.3 percent, after BAML upped its price target on the stock.

The company, embroiled in a lengthy legal battle with India’s Dr. Reddy’s over a copycat version of its opioid addiction drug, has seen its shares sink 77.4 percent this year.

Small-cap recruiting firm Sthree (L:STHR) climbed 3.8 percent after it raised its forecast for annual profits thanks to stronger international demand.

Peer Robert Walters (L:RWA) also jumped 7.9 percent.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.